2,143 Shares in Encompass Health Co. (NYSE:EHC) Bought by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC purchased a new stake in shares of Encompass Health Co. (NYSE:EHC) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,143 shares of the company’s stock, valued at approximately $207,000.

Other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. raised its position in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the last quarter. V Square Quantitative Management LLC grew its stake in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares in the last quarter. Oakworth Capital Inc. bought a new position in shares of Encompass Health during the second quarter valued at about $40,000. Benjamin F. Edwards & Company Inc. boosted its holdings in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after purchasing an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in Encompass Health in the 2nd quarter worth about $58,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on EHC shares. KeyCorp lifted their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. UBS Group lifted their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Stephens restated an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a research note on Tuesday, August 6th. Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, Truist Financial restated a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $107.11.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $101.12 on Friday. The firm has a market capitalization of $10.19 billion, a PE ratio of 24.43, a P/E/G ratio of 1.32 and a beta of 0.88. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a 50-day moving average price of $97.11 and a two-hundred day moving average price of $90.84. Encompass Health Co. has a twelve month low of $63.78 and a twelve month high of $104.55.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period last year, the firm earned $0.86 EPS. Equities analysts forecast that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s payout ratio is presently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.